These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6305671)

  • 41. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of twice-daily ranitidine and placebo in the treatment of duodenal ulcer--a multicentre study in the United Kingdom.
    Lee FI; Fielding JD; MacKay C; Mitchell K; Mohammed R; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Stone WD; Orchard RT; Calcraft BJ; Rose JA
    Hepatogastroenterology; 1982 Jun; 29(3):127-9. PubMed ID: 6125463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK; DiCicco RA; Freed MI
    Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
    Howden CW; Tsai HH; Reid JL
    Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
    Gabryelewicz A; Konturek SJ; Butruk E; Dzieniszewski J; Marlicz K; Nowak A; Torres J; Marquez M; Ortiz JA
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibiting acid and Helicobacter pylori?
    Healey Z; Calam J
    Gut; 1997 Jul; 41(1):125-6. PubMed ID: 9274484
    [No Abstract]   [Full Text] [Related]  

  • 47. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS; Page MC; Tildesley G; Wood JR
    BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
    Holloway RH; Kuljian B; Eshelman F; McCallum RW
    Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].
    Simon B; Dammann HG; Müller P; Kather H
    Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine in long-term duodenal ulcer treatment: a multicentre trial.
    Di Mario F; Albano O; Angelini G; Cavallini G; Doronzo F; Farini R; Francavilla A; Naccarato R; Scuro LA; Vianello F
    Digestion; 1982; 24(4):260-3. PubMed ID: 6295861
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
    Richards DA
    J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer.
    Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D
    Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation.
    Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S
    Aliment Pharmacol Ther; 1990 Aug; 4(4):403-10. PubMed ID: 2103758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring.
    Savarino V; Scalabrini P; Mela GS; di Timoteo E; Percario G; Magnolia MR; Celle G
    Dig Dis Sci; 1988 Mar; 33(3):293-7. PubMed ID: 3125025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.